Logo image of IMDX

INSIGHT MOLECULAR DIAGNOSTIC (IMDX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:IMDX - US68235C2061 - Common Stock

5.34 USD
-0.17 (-3.17%)
Last: 12/3/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
IMDX revenue by date.IMDX revenue by date.
960K
-56.36%
1.503M
56.56%
1.881M
25.15%
3.341M
77.62%
3.647M
9.16%
10.761M
195.06%
EBITDA
YoY % growth
IMDX ebitda by date.IMDX ebitda by date.
7.41M
115.74%
-14.826M
-300.08%
-17.408M
-17.42%
-19.839M
-13.96%
-26.418M
-33.16%
-23.766M
10.04%
EBIT
YoY % growth
IMDX ebit by date.IMDX ebit by date.
2.19M
104.27%
-16.506M
-853.70%
-18.972M
-14.94%
-29.657M
-56.32%
-25.007M
15.68%
-23.766M
4.96%
Operating Margin
IMDX operating margin by date.IMDX operating margin by date.
228.13%-1,098.20%-1,008.61%-887.65%-685.70%-220.85%
EPS
YoY % growth
IMDX eps by date.IMDX eps by date.
-13.20
-2,900.00%
-3.60
72.73%
-4.40
-22.22%
-0.99
77.40%
-0.80
19.13%
-0.69
14.27%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.22
88.78%
-0.20
24.16%
-0.20
33.13%
-0.19
42.90%
-0.18
17.31%
-0.18
7.93%
-0.19
6.44%
-0.19
3.85%
-0.18
-0.85%
Revenue
Q2Q % growth
295.8K
-80.09%
528.36K
-75.29%
630.36K
21.69%
870.57K
234.83%
349.86K
18.28%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-6.834M
-169.47%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-6.697M
-180.94%
-6.6M
2.92%
-6.549M
33.45%
-6.47M
41.44%
-5.159M
22.96%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.34
65.31%
-0.21-0.13-58.92%
Q2 2025
Q2Q % growth
-0.30
16.67%
-0.23-0.07-27.88%
Q1 2025
Q2Q % growth
-0.26
76.99%
-0.24-0.02-7.78%
Q4 2024
Q2Q % growth
-1.93
8.96%
-0.44-1.49-342.79%
Q3 2024
Q2Q % growth
-0.98
-20.99%
-0.44-0.54-120.36%
Q2 2024
Q2Q % growth
-0.36
66.36%
-0.570.2136.86%
Q1 2024
Q2Q % growth
-1.13
-382.50%
-0.68-0.45-65.76%
Q4 2023
Q2Q % growth
-2.12
73.50%
-1.16-0.96-82.80%
Q3 2023
Q2Q % growth
-0.81
49.38%
-1.030.2221.18%
Q2 2023
Q2Q % growth
-1.07
23.57%
-1.330.2619.31%
Q1 2023
Q2Q % growth
0.40
118.18%
-1.882.28121.31%
Q4 2022
Q2Q % growth
-8.00
-6,566.67%
-1.92-6.08-316.30%
Q3 2022
Q2Q % growth
-1.60
-966.67%
-2.300.7030.49%
Q2 2022
Q2Q % growth
-1.40
-1,066.67%
-2.431.0342.49%
Q1 2022
Q2Q % growth
-2.20
-4,300.00%
-2.450.2510.13%
Q4 2021
Q2Q % growth
-0.12
-33.33%
-0.130.017.47%
Q3 2021
Q2Q % growth
-0.15
-50.00%
-0.12-0.03-26.77%
Q2 2021
Q2Q % growth
-0.12
14.29%
-0.10-0.02-17.65%
Q1 2021
Q2Q % growth
-0.05
61.54%
-0.100.0550.98%
Q4 2020
Q2Q % growth
-0.09
35.71%
-0.110.0219.79%
Q3 2020
Q2Q % growth
-0.10 -0.100.00-3.20%
Q2 2020
Q2Q % growth
-0.14
-40.00%
-0.11-0.03-31.98%
Q1 2020
Q2Q % growth
-0.13
-62.50%
-0.11-0.02-20.24%
Q4 2019
Q2Q % growth
-0.14 -0.09-0.05-49.19%
Q3 2019
Q2Q % growth
-0.10 -0.09-0.01-14.00%
Q2 2019
Q2Q % growth
-0.10 -0.09-0.01-11.41%
Q1 2019
Q2Q % growth
-0.08 -0.090.0112.85%
IMDX Yearly EPS VS EstimatesIMDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
260K
126.09%
289.68K-29.68K-10.25%
Q2 2025
Q2Q % growth
518K
398.08%
297.84K220.16K73.92%
Q1 2025
Q2Q % growth
2.138M
1,114.77%
129.285K2.009M1,553.71%
Q4 2024
Q2Q % growth
1.486M
373.25%
102K1.384M1,356.86%
Q3 2024
Q2Q % growth
115K
-73.26%
204K-89K-43.63%
Q2 2024
Q2Q % growth
104K
-77.39%
324.87K-220.87K-67.99%
Q1 2024
Q2Q % growth
176K
-41.33%
357K-181K-50.70%
Q4 2023
Q2Q % growth
314K
16.30%
323.003K-9.003K-2.79%
Q3 2023
Q2Q % growth
430K
514.29%
318.75K111.25K34.90%
Q2 2023
Q2Q % growth
460K
91.67%
369.75K90.25K24.41%
Q1 2023
Q2Q % growth
300K
-21.05%
353.328K-53.328K-15.09%
Q4 2022
Q2Q % growth
270K
113.92%
1.453M-1.183M-81.42%
Q3 2022
Q2Q % growth
70K
-92.86%
1.514M-1.444M-95.38%
Q2 2022
Q2Q % growth
240K
-88.18%
2.752M-2.512M-91.28%
Q1 2022
Q2Q % growth
380K
-66.07%
2.282M-1.902M-83.35%
Q4 2021
Q2Q % growth
-1.94M
-488.00%
3.704M-5.644M-152.38%
Q3 2021
Q2Q % growth
980K
75.00%
1.795M-815K-45.40%
Q2 2021
Q2Q % growth
2.03M
1,350.00%
1.598M432K27.03%
Q1 2021
Q2Q % growth
1.12M
5,500.00%
849.997K270.003K31.77%
Q4 2020
Q2Q % growth
500K 839.797K-339.797K-40.46%
Q3 2020
Q2Q % growth
560K 378.593K181.407K47.92%
Q2 2020
Q2Q % growth
140K 48.144K91.856K190.79%
IMDX Yearly Revenue VS EstimatesIMDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.79% -3.79% 0% -0.17%
Revenue-19.22% 4.07% 0% 3.44%